HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1 [Yahoo! Finance]
HeartSciences Inc. (HSCS)
Company Research
Source: Yahoo! Finance
Southlake, TX, Dec. 11, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company advancing the use of ECG/EKGs through the integration of artificial intelligence (“AI”), today announced the commercial release of MyoVista Insights™ version 1.1 , a major update that is built to provide the most usable ECG system and enhances clinical interpretation capabilities, improves workflow efficiency, and expands interoperability across a broad range of ECG devices. Andrew Simpson, CEO of HeartSciences said, “MyoVista Insights is a state-of-the-art ECG reporting and management platform that delivers substantial clinical, operational, and data-security benefits for healthcare systems, since its launch in May 2025, we've received strong validation from early adopters and are engaged in commercial discussions with several leading healthcare institutions. We look forward to announcing key customer depl
Show less
Read more
Impact Snapshot
Event Time:
HSCS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HSCS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HSCS alerts
High impacting HeartSciences Inc. news events
Weekly update
A roundup of the hottest topics
HSCS
News
- Heart Test Laboratories reports Q2 results [Seeking Alpha]Seeking Alpha
- HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business UpdateGlobeNewswire
- HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ DeviceGlobeNewswire
- HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1GlobeNewswire
- HeartSciences (NASDAQ:HSCS) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
HSCS
Analyst Actions
- 10/1/25 - Ascendiant Capital
HSCS
Sec Filings
- 12/16/25 - Form 8-K
- 12/15/25 - Form 8-K
- 12/15/25 - Form 10-Q
- HSCS's page on the SEC website